ACAD
Acadia Pharmaceuticals Inc

13,110
Mkt Cap
$4.54B
Volume
998,179.00
52W High
$28.35
52W Low
$13.40
PE Ratio
17.07
ACAD Fundamentals
Price
$26.53
Prev Close
$26.86
Open
$26.99
50D MA
$25.60
Beta
0.95
Avg. Volume
1.43M
EPS (Annual)
$1.36
P/B
4.89
Rev/Employee
$1.46M
Loading...
Loading...
News
all
press releases
Acadia Pharmaceuticals Provides Business and Pipeline Updates at 44th Annual J.P. Morgan Healthcare Conference
Acadia Pharmaceuticals Inc. (Nasdaq: ACAD) today announced multiple business updates and progress on the Company's neurological and rare disease drug candidates, which will be discussed today during...
Business Wire·2d ago
News Placeholder
More News
News Placeholder
Wall Street Jolted By Trump-Fed Fight Bloomberg Businessweek Daily 1/12/2026
On today's episode of Bloomberg Businessweek Daily, Tim Stenovec and Emily Graffeo discuss market reaction to the DOJ's subpoena of the Federal Reserve. Bloomberg's Enda Curran and Michael...
Bloomberg Markets and Finance-YouTube·3d ago
News Placeholder
FTRE vs. ACAD: Which Stock Is the Better Value Option?
FTRE vs. ACAD: Which Stock Is the Better Value Option?
Zacks·3d ago
News Placeholder
Wall Street Zen Upgrades ACADIA Pharmaceuticals (NASDAQ:ACAD) to "Buy"
Wall Street Zen upgraded shares of ACADIA Pharmaceuticals from a "hold" rating to a "buy" rating in a research note on Sunday...
MarketBeat·5d ago
News Placeholder
ACADIA Pharmaceuticals Inc. $ACAD Shares Purchased by Allspring Global Investments Holdings LLC
Allspring Global Investments Holdings LLC increased its holdings in ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 21.9% in the third quarter, according to its most recent filing with the...
MarketBeat·10d ago
News Placeholder
ACADIA Pharmaceuticals (NASDAQ:ACAD) Cut to "Hold" at Wall Street Zen
Wall Street Zen downgraded shares of ACADIA Pharmaceuticals from a "buy" rating to a "hold" rating in a research report on Saturday...
MarketBeat·13d ago
News Placeholder
Rice Hall James & Associates LLC Sells 54,869 Shares of ACADIA Pharmaceuticals Inc. $ACAD
Rice Hall James & Associates LLC reduced its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 8.2% in the 3rd quarter, according to its most recent filing with the...
MarketBeat·20d ago
News Placeholder
ACADIA Pharmaceuticals Inc. $ACAD Holdings Decreased by Assenagon Asset Management S.A.
Assenagon Asset Management S.A. trimmed its holdings in shares of ACADIA Pharmaceuticals Inc. (NASDAQ:ACAD - Free Report) by 98.4% during the 3rd quarter, according to its most recent disclosure with...
MarketBeat·21d ago
News Placeholder
ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 1-Year High - Here's Why
ACADIA Pharmaceuticals (NASDAQ:ACAD) Hits New 1-Year High - Should You Buy...
MarketBeat·24d ago
News Placeholder
Here's Why Acadia Pharmaceuticals (ACAD) is a Strong Momentum Stock
Whether you're a value, growth, or momentum investor, finding strong stocks becomes easier with the Zacks Style Scores, a top feature of the Zacks Premium research service.
Zacks·24d ago
<
1
2
...
>

Latest ACAD News

View
Top Discussions

Advertisement|Remove ads.

Advertisement|Remove ads.